Chas P. Smith & Associates (CPS)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $377K | Sell |
13,439
-2,652
| -16% | -$70.6K | 0.02% | 120 |
|
|
2025
Q4 | $401K | Buy |
16,091
+2,768
| +21% | +$69.8K | 0.02% | 119 |
|
|
2025
Q3 | $339K | Sell |
13,323
-10,295
| -44% | -$254K | 0.03% | 98 |
|
|
2025
Q2 | $572K | Sell |
23,618
-20,018
| -46% | -$467K | 0.03% | 99 |
|
|
2025
Q1 | $1.11M | Sell |
43,636
-3,220
| -7% | -$84.3K | 0.06% | 70 |
|
|
2024
Q4 | $1.24M | Sell |
46,856
-11,663
| -20% | -$316K | 0.07% | 64 |
|
|
2024
Q3 | $1.69M | Sell |
58,519
-8,562
| -13% | -$250K | 0.1% | 58 |
|
|
2024
Q2 | $1.88M | Sell |
67,081
-11,008
| -14% | -$303K | 0.11% | 56 |
|
|
2024
Q1 | $2.17M | Sell |
78,089
-12,252
| -14% | -$340K | 0.13% | 51 |
|
|
2023
Q4 | $2.6M | Sell |
90,341
-19,093
| -17% | -$577K | 0.17% | 44 |
|
|
2023
Q3 | $3.63M | Sell |
109,434
-24,039
| -18% | -$850K | 0.26% | 37 |
|
|
2023
Q2 | $4.9M | Sell |
133,473
-594,461
| -82% | -$23.1M | 0.31% | 38 |
|
|
2023
Q1 | $29.7M | Buy |
727,934
+8,108
| +1% | +$350K | 2.02% | 27 |
|
|
2022
Q4 | $36.9M | Buy |
719,826
+4,622
| +0.6% | +$222K | 2.62% | 20 |
|
|
2022
Q3 | $31.3M | Buy |
715,204
+4,550
| +0.6% | +$221K | 2.66% | 18 |
|
|
2022
Q2 | $37.3M | Buy |
710,654
+6,353
| +0.9% | +$324K | 2.69% | 17 |
|
|
2022
Q1 | $36.5M | Sell |
704,301
-1,524
| -0.2% | -$79.1K | 2.75% | 17 |
|
|
2021
Q4 | $41.7M | Sell |
705,825
-8,073
| -1% | -$400K | 2.84% | 14 |
|
|
2021
Q3 | $30.7M | Buy |
713,898
+17,710
| +3% | +$785K | 2.3% | 22 |
|
|
2021
Q2 | $27.3M | Buy |
696,188
+16,960
| +2% | +$660K | 2.12% | 27 |
|
|
2021
Q1 | $24.6M | Buy |
679,228
+29,359
| +5% | +$1.04M | 2.31% | 24 |
|
|
2020
Q4 | $23.9M | Sell |
649,869
-19,421
| -3% | -$712K | 2.4% | 25 |
|
|
2020
Q3 | $23.3M | Sell |
669,290
-4,535
| -0.7% | -$159K | 2.62% | 23 |
|
|
2020
Q2 | $20.9M | Sell |
673,825
-2,820
| -0.4% | -$95.8K | 2.54% | 23 |
|
|
2020
Q1 | $21M | Buy |
676,645
+15,949
| +2% | +$543K | 2.9% | 16 |
|
|
2019
Q4 | $24.6M | Buy |
660,696
+2,109
| +0.3% | +$75.1K | 2.67% | 20 |
|
|
2019
Q3 | $22.5M | Sell |
658,587
-2,651
| -0.4% | -$96.4K | 2.59% | 24 |
|
|
2019
Q2 | $27.2M | Sell |
661,238
-18,674
| -3% | -$742K | 3.2% | 8 |
|
|
2019
Q1 | $27.4M | Sell |
679,912
-14,174
| -2% | -$568K | 3.36% | 8 |
|
|
2018
Q4 | $28.7M | Sell |
694,086
-21,813
| -3% | -$906K | 3.9% | 3 |
|
|
2018
Q3 | $29.9M | Sell |
715,899
-7,031
| -1% | -$271K | 3.65% | 5 |
|
|
2018
Q2 | $24.9M | Buy |
722,930
+10,976
| +2% | +$375K | 3.34% | 9 |
|
|
2018
Q1 | $24M | Buy |
711,954
+12,116
| +2% | +$417K | 3.33% | 9 |
|
|
2017
Q4 | $24M | Buy |
699,838
+17,766
| +3% | +$606K | 3.22% | 11 |
|
|
2017
Q3 | $23.1M | Sell |
682,072
-7,708
| -1% | -$248K | 3.3% | 10 |
|
|
2017
Q2 | $22M | Buy |
689,780
+6,283
| +0.9% | +$198K | 3.21% | 12 |
|
|
2017
Q1 | $22.2M | Buy |
683,497
+62,166
| +10% | +$1.96M | 3.3% | 9 |
|
|
2016
Q4 | $19.1M | Sell |
621,331
-599,514
| -49% | -$18.3M | 3.04% | 12 |
|
|
2016
Q3 | $39M | Buy |
1,220,845
+616,223
| +102% | +$20.6M | 3.32% | 6 |
|
|
2016
Q2 | $20.2M | Buy |
604,622
+497
| +0.1% | +$15.9K | 3.4% | 6 |
|
|
2016
Q1 | $17M | Sell |
604,125
-2,259
| -0.4% | -$64.5K | 2.9% | 12 |
|
|
2015
Q4 | $18.6M | Buy |
606,384
+544
| +0.1% | +$17.1K | 3.28% | 7 |
|
|
2015
Q3 | $18.1M | Sell |
605,840
-11,215
| -2% | -$360K | 3.48% | 7 |
|
|
2015
Q2 | $19.6M | Buy |
617,055
+8,760
| +1% | +$286K | 3.44% | 9 |
|
|
2015
Q1 | $20.1M | Buy |
608,295
+4,398
| +0.7% | +$140K | 3.6% | 9 |
|
|
2014
Q4 | $17.8M | Buy |
603,897
+16,941
| +3% | +$486K | 3.23% | 9 |
|
|
2014
Q3 | $16.5M | Buy |
586,956
+32,641
| +6% | +$916K | 3.27% | 8 |
|
|
2014
Q2 | $15.6M | Sell |
554,315
-1,063,039
| -66% | -$30.3M | 3.17% | 8 |
|
|
2014
Q1 | $49.3M | Buy |
1,617,354
+32,497
| +2% | +$969K | 3.63% | 4 |
|
|
2013
Q4 | $46.1M | Buy |
1,584,857
+1,065,617
| +205% | +$31M | 3.56% | 5 |
|
|
2013
Q3 | $14.2M | Buy |
519,240
+14,450
| +3% | +$393K | 3.62% | 3 |
|
|
2013
Q2 | $13.4M | Buy |
+504,790
| New | +$13.9M | 3.57% | 2 |
|
Other funds holding PFE
VCM
VPM
Chas P. Smith & Associates (CPS)'s PFE Position: Q1 2026 in Review
Chas P. Smith & Associates (CPS) reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $70.6K and leaving 13,439 shares worth $377K. The position accounts for 0.02% of the portfolio, ranked #120.
Chas P. Smith & Associates (CPS) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.3M in Q1 2014. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Chas P. Smith & Associates (CPS) held 13,439 shares of Pfizer worth $377K as of Q1 2026.
- Chas P. Smith & Associates (CPS) sold 2,652 Pfizer shares in Q1 2026, an estimated $70.6K.
- Pfizer made up 0.02% of Chas P. Smith & Associates (CPS)'s portfolio in Q1 2026, its #120 holding.
- Chas P. Smith & Associates (CPS) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Chas P. Smith & Associates (CPS)'s Pfizer position peaked at $49.3M in Q1 2014.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2026, filed 12 May 2026.